91 related articles for article (PubMed ID: 4174340)
1. Production of embryonal serum alpha-globulin by hepatomas: review of experimental and clinical data.
Abelev GI
Cancer Res; 1968 Jul; 28(7):1344-50. PubMed ID: 4174340
[No Abstract] [Full Text] [Related]
2. Identification of MCM4 as a Prognostic Marker of Hepatocellular Carcinoma.
Zhou H; Jiang L; Wang G; Su L; Hou L; Xue X
Biomed Res Int; 2021; 2021():7479326. PubMed ID: 34961841
[TBL] [Abstract][Full Text] [Related]
3. Search for Effective Serum Tumor Markers for Early Diagnosis of Hepatocellular Carcinoma Associated with Hepatitis C.
Malov SI; Malov IV; Kuvshinov AG; Marche PN; Decaens T; Macek-Jilkova Z; Yushchuk ND
Sovrem Tekhnologii Med; 2021; 13(1):27-33. PubMed ID: 34513063
[TBL] [Abstract][Full Text] [Related]
4. The Evolution of the Use of Serum Alpha-fetoprotein in Clinical Liver Cancer Surveillance.
Kelly SL; Bird TG
J Immunobiol; 2016 Dec; 1(4):. PubMed ID: 28133640
[TBL] [Abstract][Full Text] [Related]
5. Biomarkers for hepatocellular carcinoma.
Shiota G; Miura N
Clin J Gastroenterol; 2012 Jun; 5(3):177-82. PubMed ID: 26182317
[TBL] [Abstract][Full Text] [Related]
6. Combined cancer testis antigens enhanced prediction accuracy for prognosis of patients with hepatocellular carcinoma.
Wang M; Li J; Wang L; Chen X; Zhang Z; Yue D; Ping Y; Shi X; Huang L; Zhang T; Yang L; Zhao Y; Ma X; Li D; Fan Z; Zhao L; Tang Z; Zhai W; Zhang B; Zhang Y
Int J Clin Exp Pathol; 2015; 8(4):3513-28. PubMed ID: 26097535
[TBL] [Abstract][Full Text] [Related]
7. Radiomics and circulating tumor cells: personalized care in hepatocellular carcinoma?
Hesketh RL; Zhu AX; Oklu R
Diagn Interv Radiol; 2015; 21(1):78-84. PubMed ID: 25430530
[TBL] [Abstract][Full Text] [Related]
8. Hepatocellular carcinoma in a young dog.
Teshima T; Matsumoto H; Shigihara K; Sawada H; Michishita M; Takahashi K; Koyama H
Can Vet J; 2013 Sep; 54(9):845-8. PubMed ID: 24155487
[TBL] [Abstract][Full Text] [Related]
9. Sperm protein 17, MAGE-C1 and NY-ESO-1 in hepatocellular carcinoma: expression frequency and their correlation with clinical parameters.
Xia QY; Liu S; Li FQ; Huang WB; Shi LN; Zhou XJ
Int J Clin Exp Pathol; 2013; 6(8):1610-6. PubMed ID: 23923079
[TBL] [Abstract][Full Text] [Related]
10. Value of highly sensitive fucosylated fraction of alpha-fetoprotein for prediction of hepatocellular carcinoma recurrence after curative treatment.
Tamura Y; Suda T; Arii S; Sata M; Moriyasu F; Imamura H; Kawasaki S; Izumi N; Takayama T; Kokudo N; Yamamoto M; Iijima H; Aoyagi Y
Dig Dis Sci; 2013 Aug; 58(8):2406-12. PubMed ID: 23595518
[TBL] [Abstract][Full Text] [Related]
11. An overview of biomarkers for the diagnosis of hepatocellular carcinoma.
Abu El Makarem M
Hepat Mon; 2012 Oct; 12(10 HCC):e6122. PubMed ID: 23162601
[TBL] [Abstract][Full Text] [Related]
12. Secretome survey of human plexiform neurofibroma derived Schwann Cells reveals a secreted form of the RARRES1 protein.
Chen HL; Seol H; Brown KJ; Gordish-Dressman H; Hill A; Gallo V; Packer R; Hathout Y
Int J Mol Sci; 2012; 13(7):9380-9399. PubMed ID: 22942771
[TBL] [Abstract][Full Text] [Related]
13. Comparative diagnostic efficacy of serum squamous cell carcinoma antigen in hepatocellular carcinoma.
Soyemi OM; Otegbayo JA; Ola SO; Akere A; Soyemi T
BMC Res Notes; 2012 Aug; 5():403. PubMed ID: 22856336
[TBL] [Abstract][Full Text] [Related]
14. The efficacy of miRNA122, a novel therapeutic target, for predicting the progression of hepatocellular carcinoma (HCC).
Wang L; Zhang Z; Wang FS
Cell Mol Immunol; 2012 Mar; 9(2):103-4. PubMed ID: 21983871
[No Abstract] [Full Text] [Related]
15. Novel Lens culinaris agglutinin-reactive fraction of α-fetoprotein: a biomarker of hepatocellular carcinoma recurrence in patients with low α-fetoprotein concentrations.
Morimoto M; Numata K; Nozaki A; Kondo M; Moriya S; Taguri M; Morita S; Konno M; Sugo A; Miyajima E; Maeda S; Tanaka K
Int J Clin Oncol; 2012 Aug; 17(4):373-9. PubMed ID: 21847534
[TBL] [Abstract][Full Text] [Related]
16. Clinical advantage of highly sensitive on-chip immunoassay for fucosylated fraction of alpha-fetoprotein in patients with hepatocellular carcinoma.
Tamura Y; Igarashi M; Kawai H; Suda T; Satomura S; Aoyagi Y
Dig Dis Sci; 2010 Dec; 55(12):3576-83. PubMed ID: 20407827
[TBL] [Abstract][Full Text] [Related]
17. Present and future possibilities for early diagnosis of hepatocellular carcinoma.
Stefaniuk P; Cianciara J; Wiercinska-Drapalo A
World J Gastroenterol; 2010 Jan; 16(4):418-24. PubMed ID: 20101765
[TBL] [Abstract][Full Text] [Related]
18. Hepatoid adenocarcinoma of the stomach - a different histology for not so different gastric adenocarcinoma: a case report.
Gálvez-Muñoz E; Gallego-Plazas J; Gonzalez-Orozco V; Menarguez-Pina F; Ruiz-Maciá JA; Morcillo MA
Int Semin Surg Oncol; 2009 Aug; 6():13. PubMed ID: 19674468
[TBL] [Abstract][Full Text] [Related]
19. Serum alpha-fetoprotein levels during and after interferon therapy and the development of hepatocellular carcinoma in patients with chronic hepatitis C.
Tamura Y; Yamagiwa S; Aoki Y; Kurita S; Suda T; Ohkoshi S; Nomoto M; Aoyagi Y;
Dig Dis Sci; 2009 Nov; 54(11):2530-7. PubMed ID: 19093203
[TBL] [Abstract][Full Text] [Related]
20. Usefulness of cancer-testis antigens as biomarkers for the diagnosis and treatment of hepatocellular carcinoma.
Grizzi F; Franceschini B; Hamrick C; Frezza EE; Cobos E; Chiriva-Internati M
J Transl Med; 2007 Jan; 5():3. PubMed ID: 17244360
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
